Natus Medical Net Cash Flow from Financing Trend

Natus Medical Incorporated -- USA Stock  

USD 30.85  0.15  0.49%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Net Cash Flow from Financing of Natus Medical Incorporated with missing and latest data points interpolated. A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities, from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares, issuance (repayment) of debt securities, and payment of dividends & other cash distributions.
Net Cash Flow from Financing  10 Years Trend  
 Net Cash Flow from Financing 

Natus Medical Net Cash Flow from Financing Over Time

2016-12-31  118,417,000 
2017-12-31  118,417,000 
2018-12-31  62,762,632 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  38,351,202
Coefficient Of Variation  117.22
Mean Deviation  36,110,557
Median  33,417,000
Standard Deviation  44,954,453
Range  139,331,000
R Value  0.29
R Squared  0.082247
Significance  0.34
Slope  3,310,455

Currently Trending

Sold over 20 shares of
a day ago ago
Traded for 121.85
Purchased over 500 shares of
a day ago ago
Traded for 5.39
Purchased over 200 shares of
a day ago ago
Traded for 10.61